Press Release

KAKEN Pharmaceutical to Increase Year-end Dividend for the 83rd Fiscal Year Ended March 2003April 24, 2003

 Kaken Pharmaceutical Co., Ltd. (president: Shiro Inui; Code No.: TSE First Section 4521) decided to increase the year-end dividend for the fiscal year ended March 2003 as shown below at a board meeting on April 24, 2003.

 

1.Reason
 Kaken Pharmaceutical makes it its policy to return profits to its shareholders according to its business performance while building up an internal reserve sufficient for business development in the future. In accordance with this policy, its board of directors decided to propose the following increase in the year-end dividend at the 83rd regular shareholders’ meeting scheduled for the end of June 2003.

 

2.Proposed dividends

Mid-year dividend Year-end dividend Annual dividend
Earlier forecast made on November 21, 2002  ¥3.75  ¥3.75   ¥7.50
Revised forecast  ¥3.75  ¥4.50   ¥8.25
Dividend per share in the previous fiscal year  ¥3.75 ¥3.75   ¥7.50

Back to list